Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues.
about
Technical advances in proteomics: new developments in data-independent acquisitionApplications of targeted proteomics in systems biology and translational medicineAdvances in targeted proteomics and applications to biomedical researchQuantification of SAHA-Dependent Changes in Histone Modifications Using Data-Independent Acquisition Mass SpectrometryAdvancing Urinary Protein Biomarker Discovery by Data-Independent Acquisition on a Quadrupole-Orbitrap Mass SpectrometerReproducible quantitative proteotype data matrices for systems biology.Systematic evaluation of data-independent acquisition for sensitive and reproducible proteomics-a prototype design for a single injection assay.High-precision iRT prediction in the targeted analysis of data-independent acquisition and its impact on identification and quantitation.Untargeted, spectral library-free analysis of data-independent acquisition proteomics data generated using Orbitrap mass spectrometers.SWATH-MS data of Drosophila melanogaster proteome dynamics during embryogenesisGeneration of High-Quality SWATH® Acquisition Data for Label-free Quantitative Proteomics Studies Using TripleTOF® Mass Spectrometers.Automated SWATH Data Analysis Using Targeted Extraction of Ion Chromatograms.Mechanisms of acetaminophen hepatotoxicity and their translation to the human pathophysiology.Standardized Profiling of The Membrane-Enriched Proteome of Mouse Dorsal Root Ganglia (DRG) Provides Novel Insights Into Chronic Pain.Current state of the art for enhancing urine biomarker discovery.Comparative Proteomic Characterization of 4 Human Liver-Derived Single Cell Culture Models Reveals Significant Variation in the Capacity for Drug Disposition, Bioactivation, and Detoxication.SWATH-MS dataset of heat-shock treated Drosophila melanogaster embryos.Fuzzy-FishNET: a highly reproducible protein complex-based approach for feature selection in comparative proteomicsSWATH-MS as a tool for biomarker discovery - from basic research to clinical applications.New targeted approaches for the quantification of data-independent acquisition mass spectrometry.Clinical applications of quantitative proteomics using targeted and untargeted data-independent acquisition techniques.ROTS: An R package for reproducibility-optimized statistical testingAnalysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry.SWATH Mass Spectrometry Performance Using Extended Peptide MS/MS Assay Libraries.A multicenter study benchmarks software tools for label-free proteome quantification.Exploring novel paths towards protein signatures of chronic painData Independent Acquisition of HLA Class I Peptidomes on the Q Exactive Mass Spectrometer Platform.Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry.Statistical control of peptide and protein error rates in large-scale targeted data-independent acquisition analyses.Enhanced differential expression statistics for data-independent acquisition proteomics.pyQms enables universal and accurate quantification of mass spectrometry data.Quantitative proteomics: challenges and opportunities in basic and applied research.Identification of protein adduction using mass spectrometry: Protein adducts as biomarkers and predictors of toxicity mechanisms.A comprehensive evaluation of popular proteomics software workflows for label-free proteome quantification and imputation.Lipid peroxidation and tyrosine nitration in traumatic brain injury: Insights into secondary injury from redox proteomics.An IonStar Experimental Strategy for MS1 Ion Current-Based Quantification Using Ultrahigh-Field Orbitrap: Reproducible, In-Depth, and Accurate Protein Measurement in Large Cohorts.Tandem mass spectral libraries of peptides and their roles in proteomics research.DIA is not a new mass spectrometry acquisition method.A systematic evaluation of normalization methods in quantitative label-free proteomics.Organ-on-a-chip devices advance to market.
P2860
Q26752450-60A3A2B1-299A-4BC8-B111-8402B1C5FF86Q26852271-DF4890B7-56F5-4421-82C3-2223D90EECB4Q28066912-C5F023B7-93AD-443D-9DE6-71A5C0BD8316Q30977451-76389150-2BB2-445E-9460-F0B90FEB4FADQ30999645-87D80438-B876-4A15-82EC-93F9429F2FE8Q31018998-777DB861-7DC0-4ED5-8A81-8E862D1BC083Q31036432-B506FEDF-94C9-42BB-9DCF-8EE7432EBF14Q31099853-FD86FD45-E01F-496B-9C60-9BC366323D54Q31104498-B2444087-06E2-4C9B-8125-92941A696F66Q31142327-E615590C-ECC8-49F5-AADC-3C884B1BC1C8Q31161206-787492E5-33E8-4E2E-AF67-1F0E9FEABCF7Q31161210-8CF9A715-A16C-49E3-A3C6-1832DA5B1DB3Q33848167-02B70D2C-F153-4A32-8BA0-99318FE59CF3Q35996699-9E2698E9-9C3B-442E-A089-01191E26A871Q36032361-28FEDFDE-D93C-4F16-A3E3-93BF80F425C4Q36093125-D89F36E8-43B9-47F4-9EB1-C19449E94E24Q36207375-13727303-1A80-4133-9114-817D7F84D1EAQ36258523-3423B1E7-44F5-4B89-846D-A1E0512D95F5Q36262132-B489B122-8E1F-4AA1-80B2-25A00B8B53B6Q36315078-F926EED8-4EE8-4272-84DC-754C459F3FC1Q36354836-D467085F-D772-476E-B24B-0A2A186FD348Q36380107-7AC7F29C-9184-4BAA-93FD-63696459B5A9Q36604367-6175E2C6-966B-4566-B2F5-60F8EDA7E620Q37076913-D9725A32-0C97-4310-A2D1-E1FD109EE4FFQ37432423-81C8D52A-6B39-456F-9EB9-B6B4B5AFCADEQ37495675-EF2DF7BD-F364-44D5-AF14-7826339DB0C7Q38611717-DA68E7C9-6A6F-4CD3-9E2B-3234E2863FC4Q38615341-F7F6058A-9FAC-46A0-A2FA-0409968EAE28Q38616270-931D7CBC-EE2F-42D5-9ADC-049130DAFB79Q38654893-FE2A8CD7-8689-4EA9-9F9F-C2BDE6EEBE61Q38669191-30A43438-6266-46B0-90EF-C2BBCBFFC252Q38676266-116A4DB0-AB75-4437-A292-0C6F6A14ABF7Q38722096-8C37A501-EB26-4BD8-A800-9AA8526C08CCQ38748537-42F6F942-4276-4524-B613-9A75DC279F4DQ38824992-5427E4D1-1820-40CB-97D6-31E574A54999Q38835346-8947037C-08FF-4C14-9306-21A9DCEDF7F7Q38893673-D248D365-63D4-4B1B-8809-A753A63D2739Q38994195-6912FFB2-5939-4F11-8E54-8471521813E0Q39330843-DDC02008-7EB1-44DC-86DE-A3C4A832B4D8Q39375469-E400B1AE-F7FA-4B56-B236-7497E04539E8
P2860
Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Extending the limits of quanti ...... imensional liver microtissues.
@ast
Extending the limits of quanti ...... imensional liver microtissues.
@en
type
label
Extending the limits of quanti ...... imensional liver microtissues.
@ast
Extending the limits of quanti ...... imensional liver microtissues.
@en
prefLabel
Extending the limits of quanti ...... imensional liver microtissues.
@ast
Extending the limits of quanti ...... imensional liver microtissues.
@en
P2093
P2860
P356
P1476
Extending the limits of quanti ...... dimensional liver microtissues
@en
P2093
Claudia Escher
Lin-Yang Cheng
Lukas Reiter
Olga Vitek
Oliver M Bernhardt
Oliver Rinner
Roland Bruderer
Saša M Miladinović
Simon Messner
Tejas Gandhi
P2860
P304
P356
10.1074/MCP.M114.044305
P577
2015-02-27T00:00:00Z